🏛️ Enterprise AI Platform & Governance

This section covers corporate investment behaviour of pharmaceutical companies, not the efficacy or safety of any medicinal product. Headlines are quoted as published; no claim about product performance is made or implied by this site. Collection and classification are automated and may misclassify or miss items. Disclaimer

• 2026-11-04
  S2 Deal / PartnershipTempus AI shares rise more than 10% on first adjusted profit and expanded partnerships — Traders Union11/03 04:28 JSTTempus AI
• 2026-11-03
  S4 Amount disclosed[Tempus AI Q3 2026 Earnings Call] Tempus AI Turns First Profit as Revenue Jumps 23% to $411.5M; Raises Full-Year Guidance to $1.60B-$1.605Bplanned $1.605B — BigGo Finance11/02 23:54 JSTTempus AIAlso reported by 1: grafa.com
• 2026-11-03
  S4 Amount disclosednPhase Secures $30 Million in Series D Funding to Drive Global Expansion of AI-Native Clinical Data Platform for Life Sciences$30 Million — FinancialContent11/02 21:07 JST
• 2026-11-03
  S4 Amount disclosedCathie Wood's Ark Invest Buys $12M in Tempus AI Stock Amid Bullish Wall Street Calls$12M — CoinCodex11/02 21:58 JSTTempus AI
• 2026-11-03
  S3 Capital moveTempus AI Q3 revenue slightly beats estimates; raises guidance — TradingView11/02 21:09 JSTTempus AI
• 2026-11-03
  S3 Capital moveTempus AI Soars 10% on Q3 Beat and Raised Guidance as Oncology Sees “Accelerating Unit Growth” — TIKR.com11/03 02:04 JSTTempus AI
• 2026-10-31
  S4 Amount disclosedAstraZeneca signs up to $247M AI antibody discovery deal with Absciup to $247M — Dealroom10/30 16:10 JSTAstraZenecaAbsci
• 2026-10-31
  S4 Amount disclosedTempus AI(TEM.US) 10% Shareholder Sells US$17.59 Million in Common StockUS$17.59 Million — Moomoo10/30 07:00 JSTTempus AI
• 2026-10-31
  S3 Capital moveAnthropic acquires biotech startup exploring AI-led drug development — European Pharmaceutical Review10/30 20:07 JSTAnthropic
• 2026-10-31
  S2 Deal / PartnershipChinese AI drug firm XtalPi expands Singapore partnership — Tech in Asia10/30 09:18 JST
• 2026-10-30
  S4 Amount disclosedCatalan biotech Allox raises €9.4M to advance AI drug-discovery platform€9.4M — Dealroom10/29 20:49 JST
• 2026-10-30
  S2 Deal / PartnershipDae Woong Pharmaceutical partners with Higashinada City Hospital to build a smart ward at the Seoul AI Expo — BigGo ファイナンス10/29 09:55 JST
• 2026-10-30
  S2 Deal / PartnershipAnthropic publishes results of collaboration with 6 pharmaceutical companies: regulatory document review time cut by 89%, and human oversights also detected — an AI utilization guide for small and medium-sized businesses in Kurume and Fukuoka — https://ai-hikari-ai.com/10/29 09:24 JSTAnthropic
• 2026-10-29
  S4 Amount disclosedBeijing-based BioGeometry gets $100M+ for AI drug R&D$100M — Endpoints News10/28 23:08 JST
• 2026-10-29
  S2 Deal / PartnershipAppian and PSI CRO Form Strategic Partnership to Advance AI-driven Clinical Trial Operations — PR Newswire10/28 19:00 JST
• 2026-10-29
  S2 Deal / PartnershipAnthropic Partners with Six Life Sciences Organizations to Advance Drug Development with Claude — Digital Health News10/28 18:21 JSTAnthropic
• 2026-10-29
  S1 DeploymentCaution and Pharma’s AI Adoption: Understanding the Reasons Behind Uneven Uptake — Pharmaceutical Executive10/28 19:08 JST
• 2026-10-27
  S4 Amount disclosedPathos AI Secures $237 Million in Series E Financing to Scale Agentic AI Drug Development Platform and Advance Oncology Pipeline$237 Million — BioSpace10/26 12:12 JST
• 2026-10-25
  S4 Amount disclosedTempus AI and Pathos AI Sign Neurology Data Deal Worth Up to $55 Millionup to $55 Million — www.tokenpost.com10/24 21:09 JSTTempus AI
• 2026-10-25
  S2 Deal / PartnershipTempus AI, Inc. Enters Into Multi-Year Agreement With Bristol Myers Squibb To License Multimodal Oncology Data — marketscreener.com10/24 04:21 JSTBristol Myers SquibbTempus AI
• 2026-10-25
  S1 DeploymentFrom ECGs to AI-powered Care: Tricog Health scales global ambitions with Sanofi & OMRON Healthcare — Indian Pharma Post10/24 14:00 JSTSanofi
• 2026-10-24
  S4 Amount disclosedAI drug firm Pathos raises $237 million, pushing valuation to $3 billionvaluation $3 billion — STAT10/23 22:04 JSTAlso reported by 1: STAT News
• 2026-10-24
  S2 Deal / PartnershipPathos AI teams up with Bristol Myers and Tempus AI to advance drug development — Reuters10/23 22:01 JSTTempus AI
• 2026-10-22
  S4 Amount disclosedThe $400B Pharma Backend Is Getting an AI Shakeup—and Hourly Billing Is Dead$400B — GeneOnline10/21 15:00 JST
• 2026-10-22
  S4 Amount disclosedAstellas links up with AI Proteins in $400M computational d rugdiscovery deal$400M — Fierce Biotech10/21 22:14 JSTAstellas
• 2026-10-22
  S4 Amount disclosedAI Proteins Announces Research Collaboration and License Agreement With Astellas Pharma to Discover and Develop Novel Miniprotein-Based Therapeutics Valued at Over $400 Millionvaluation $400 Million — Business Wire10/21 21:00 JSTAstellas
• 2026-10-22
  S3 Capital moveOpenAI acquires Orchestra Bio, accelerating new drug development - CHOSUNBIZ — Chosunbiz10/21 09:35 JST
• 2026-10-21
  S4 Amount disclosedMETiS Therapeutics partners with Eli Lilly on AI drug-delivery technology: over $10 million upfront, milestones of up to about ¥170 billionup to ¥170 billion — BigGo ファイナンス10/20 11:55 JSTEli Lilly
• 2026-10-21
  S4 Amount disclosedAstraZeneca Taps Oracle as Lilly Inks Up to $1.1B AI Dealup to $1.1B — FourWeekMBA10/20 17:22 JSTAstraZenecaAlso reported by 3: TradingView · TNGlobal · FirstWord Pharma
• 2026-10-21
  S4 Amount disclosed$1.1B China's First Large Generative AI-LNP Platform Overseas Export Deal Landed | Eli Lilly's Bulk Acquisition Logic Shift$1.1B — 36Kr10/20 13:53 JSTEli Lilly
• 2026-10-21
  S4 Amount disclosedCapable raises $38M seed to build AI drug-discovery lab$38M — Dealroom10/21 01:29 JST
• 2026-10-21
  S2 Deal / PartnershipAstraZeneca partners with Oracle for AI-driven clinical trials — Reuters10/21 01:10 JSTAstraZenecaAlso reported by 5: WSJ · TradingView · BigGo Finance · Yahoo Finance · Yahoo Finance UK
• 2026-10-21
  S2 Deal / PartnershipAstraZeneca and Oracle launch global AI collaboration to advance clinical trial optimisation and support better patient outcomes — AstraZeneca10/20 13:00 JSTAstraZenecaAlso reported by 3: Dealroom · marketscreener.com · Mirage News
• 2026-10-21
  S2 Deal / PartnershipAstraZeneca (LSE:AZN) Could Be 22% Undervalued On AI Partnership And Pipeline Updates — Yahoo Finance10/20 21:11 JSTAstraZeneca
• 2026-10-21
  S2 Deal / PartnershipInsilico Medicine and Servier Achieve First Milestone in AI-Driven R&D Collaboration, Triggering An undisclosed Milestone Payment — TradingView10/20 22:00 JSTServierInsilico Medicine
• 2026-10-21
  S2 Deal / PartnershipOracle partners with AstraZeneca to deploy AI, aiming to speed up patient screening for clinical trials — BigGo ファイナンス10/20 16:25 JST
• 2026-10-21
  S2 Deal / PartnershipVistagen Selects GATC Health to Apply Predictive AI Across Lead Clinical-Stage Drug Development Programs — BioSpace10/20 22:39 JST
• 2026-10-21
  S1 DeploymentPharma's digital maturity divide that is impairing AI adoption — Manufacturing Chemist10/20 16:00 JST
• 2026-10-20
  S4 Amount disclosedLilly partners with Hong Kong's Metis in $1.1B deal to bolster AI nanoparticle discovery$1.1B — Fierce Biotech10/19 23:45 JST
• 2026-10-20
  S4 Amount disclosedMETiS TechBio, Eli Lilly Sign AI-Driven Drug-Delivery Deal With Up to $1.1 Billion in Milestonesup to $1.1 Billion — marketscreener.com10/19 20:19 JSTEli Lilly
• 2026-10-20
  S1 DeploymentAI Tracking in Biopharma: Accelerated Large-Scale Deployment by Major Pharma Companies; Valuation Re-rating Hinges on R&D Productivity Gains — 富途牛牛10/19 15:02 JST
• 2026-10-17
  S4 Amount disclosedVertex Ventures leads $29m round in Indian AI startup$29m — Tech in Asia10/16 18:12 JSTVertexAlso reported by 1: The Economic Times
• 2026-10-16
  S4 Amount disclosedAstraZeneca bulks up MASH, cardio work in up to $1.5B AI partnership with insitroup to $1.5B — BioSpace10/15 23:44 JSTAstraZeneca
• 2026-10-16
  S3 Capital moveParkourSC Acquires Quartic To Launch Unified AI Platform For Life Sciences Supply Chains — Pulse 2.010/15 05:20 JST
• 2026-10-16
  S2 Deal / PartnershipAstraZeneca announces new strategic collaboration with insitro to use advanced AI systems to develop transformative therapeutics for difficult to treat cardiometabolic diseases — AstraZeneca10/15 14:30 JSTAstraZeneca
• 2026-10-16
  S2 Deal / PartnershipRecursion Pharmaceuticals Announces Sanofi Options First Development Candidate from AI-Driven Collaboration — Quiver Quantitative10/15 21:51 JSTSanofiRecursion
• 2026-10-15
  S4 Amount disclosedNuveen Asset Management released a market commentary stating that artificial intelligence (AI) is reshaping the economic structure of the biopharmaceutical industry. Nuveen manages assets of 2.6 trillion dollars (about 4008 trillion won).$600 billion — 매일경제10/14 14:09 JST
• 2026-10-15
  S4 Amount disclosedGlobal Life Sciences IT Market Opportunities and Strategies to 2035 | Capitalize on AI, Cloud and Bioinformatics as IQVIA, Oracle, Accenture, Veeva Systems and SAP Target $82.24Bplanned $82.24B — Yahoo Finance UK10/14 17:01 JSTVeevaIQVIA
• 2026-10-15
  S4 Amount disclosedNasdaq listing awaits Singapore’s US$1.5 billion AI drug-discovery biotech Nanyang BiologicsUS$1.5 billion — The Business Times10/14 16:00 JST
• 2026-10-15
  S4 Amount disclosedZealand Pharma, Generate strike AI obesity drug deal worth up to $1.2 billionup to $1.2 billion — WTVB10/14 14:37 JSTAlso reported by 1: Global Banking & Finance Review
• 2026-10-15
  S4 Amount disclosedThinkTrends Lands $49 Million IDIQ Contract from the U.S. Food and Drug Administration for AI and Data Implementation Support$49 Million — The Globe and Mail10/15 00:00 JST
• 2026-10-15
  S2 Deal / PartnershipZealand Pharma and Generate Biomedicines Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases — The Manila Times10/14 05:46 JSTGenerate BiomedicinesAlso reported by 1: BioSpace
• 2026-10-15
  S2 Deal / PartnershipWaters Partners with Anthropic to Advance AI-Driven Autonomous Laboratory Workflows — BioPharma APAC10/14 12:14 JSTAnthropic
• 2026-10-15
  S1 Deployment"Technological Progress Outpaced Adoption" — The Real Lesson From a Decade of AI in Pharma — AIM Media House10/14 15:10 JST
• 2026-10-14
  S4 Amount disclosedVertex Ventures leads $3m seed in AI science startup Drylab$3m — Tech in Asia10/13 13:31 JSTVertex
• 2026-10-14
  S2 Deal / PartnershipPharma executives sentenced in $92M black-market HIV drug scheme; Trump reveals Rep. Neal Dunn’s serious heart diagnosis; AI model improves accuracy of cardiac ultrasound diagnoses – Morning Medical Update — Medical Economics10/13 06:52 JST
• 2026-10-14
  S1 DeploymentIGC Pharma Unveils PRISM AI Platform to Move Alzheimer's Risk Prediction to Brain-Health Action and Commercial Deployment — BioSpace10/13 22:28 JST
• 2026-10-14
  S1 DeploymentMedical paper search AI introduced at Suntory Global Innovation Center, FRONTEO — 医薬通信社10/13 17:11 JST
• 2026-10-13
  S2 Deal / PartnershipKorea's Lunit collaborates with US-based Discovery Life Sciences to expand AI-powered tissue analysis for biopharma research — BioSpectrum Asia10/12 20:22 JST
• 2026-10-11
  S2 Deal / PartnershipBeijing Haizhi and Jointown Forge AI Partnership for Pharma Distribution Upgrade — The Globe and Mail10/10 20:41 JST
• 2026-10-11
  S1 DeploymentCRB Survey Finds AI Adoption Lagging in Regulated Biopharma Operations — Lab Manager10/10 08:54 JST
• 2026-10-10
  S4 Amount disclosedKey facts: Tempus AI (TEM) Q2 $382.5M; Oncology Model for AstraZeneca$382.5M — TradingView10/09 16:00 JSTAstraZenecaTempus AI
• 2026-10-10
  S4 Amount disclosedIambic sets IPO terms, seeking $150 million to advance AI-designed cancer drugsplanned $150 million — The Pharma Letter10/09 20:15 JST
• 2026-10-10
  S3 Capital moveSopris Capital Acquires Blackford Analysis from Bayer, Plans Integration with Azra AI — citybiz10/09 23:39 JSTBayer
• 2026-10-10
  S3 Capital moveNvidia-backed AI biotech Iambic seeks up to USD 159m in IPO — MedWatch10/09 17:12 JST
• 2026-10-10
  S2 Deal / PartnershipOxyContin maker Purdue Pharma set to dissolve after $5B sentence; Mayo Clinic AI detects pancreatic cancer years before diagnosis; results of FDA’s largest-ever infant formula test – Morning Medical Update — Medical Economics10/09 20:14 JST
• 2026-10-10
  S1 DeploymentPfizer Handed AI to Its Business Leaders. Adoption Sped Up — Business Model Analyst10/09 21:54 JSTPfizer
• 2026-10-09
  S4 Amount disclosedNVIDIA, Eli Lilly Plan Up to $1 Billion for AI Drug Labup to $1 Billion — www.tokenpost.com10/08 23:41 JSTEli Lilly
• 2026-10-09
  S3 Capital moveiM Securities Raises Hanmi Pharmaceutical Target to ₩650,000, Reflecting AI-Designed Obesity Drug Value — BigGo Finance10/08 09:55 JST
• 2026-10-09
  S3 Capital moveNVIDIA's 3-Year $X Investment in 14 AI Pharma Startups: Is a Wave of Star-Studded AI Pharmaceutical IPOs On the Horizon? — 36Kr10/08 14:11 JST
• 2026-10-09
  S2 Deal / PartnershipSeeq Collaborates with Cognizant to Accelerate Industrial AI Adoption in Life Sciences — Morningstar10/08 21:36 JST
• 2026-10-09
  S2 Deal / PartnershipSimulations Plus Announces Funded Partnership with Global Pharmaceutical Company to Advance AI-Enabled QSP Model Development with Turin — Yahoo Finance10/08 22:15 JST
• 2026-10-09
  S2 Deal / PartnershipPRISM BioLab: Hit rate above 70% through proprietary technology and AI, aiming for medium- to long-term growth with pipeline expansion and progress in partnerships with major pharmaceutical companies — ｄメニューニュース10/08 11:18 JST
• 2026-10-09
  S1 DeploymentJT's corporate R&D organization "D-LAB" adopts medical literature search AI "KIBIT Amanogawa" from FRONTEO — 医薬通信社10/08 17:15 JST
• 2026-10-08
  S4 Amount disclosedCori Clinical Raises $4M Seed Round Led By Breega For AI Clinical Trial Platform$4M — https://ascendants.in/10/07 21:26 JST
• 2026-10-08
  S4 Amount disclosedEPFL spin-off Baio Labs lands $181,000 grant for AI drug design$181,000 — Dealroom10/07 03:52 JST
• 2026-10-08
  S3 Capital moveTempus AI, Personalis saw US merger antitrust waiting period expire — MLex10/07 06:21 JSTTempus AI
• 2026-10-08
  S2 Deal / PartnershipCognizant Extends Gilead Partnership for Five Years, Will Apply AI to DevOps — Contract Pharma10/07 02:30 JSTGileadAlso reported by 1: Siliconindia
• 2026-10-08
  S2 Deal / PartnershipRegulatory Non-Profit jobs in Article Releases Biotronik Announces Collaboration With Alivecor As First In A Series Of Strategic Partnerships To Disrupt Cardiac Digital Health With Ai Enabled Solutions | BioSpace — BioSpace10/07 10:11 JST
• 2026-10-08
  S1 DeploymentAI Deployment in Clinical Studies Requires Validation Framework and Governance Structure — The Clinical Trial Vanguard10/07 16:29 JST
• 2026-10-07
  S4 Amount disclosedTufts' Ken Getz: An AI Clinical Monitor Could Add $21 Million in Value Per Drug Program$21 Million — BigGo Finance10/06 18:08 JST
• 2026-10-07
  S1 DeploymentCompliance concerns hinder rollout of AI in drug manufacturing: Survey — BioSpace10/06 22:13 JST
• 2026-10-06
  S1 DeploymentAccelerating Evidence to Action in Pharma with Practical AI Adoption — Emerj Artificial Intelligence Research10/05 20:56 JST
• 2026-10-05
  S3 Capital moveCRScube Acquires Mednet to Expand AI-Assisted Data Entry in Clinical Trials — The Clinical Trial Vanguard10/04 21:33 JST
• 2026-10-02
  S4 Amount disclosedAI Is Reshaping Gene Transfer Technologies — $258.7 Billion in VC Signals a Structural Shift in Biotech Investment$258.7 Billion — GlobeNewswire10/01 22:38 JST
• 2026-10-02
  S2 Deal / PartnershipCellCarta and Imagene AI Expand Collaboration to Validate, Deploy and Scale AI-Powered Biomarker and Companion Diagnostic Programs Across Drug Development — PR Newswire10/01 22:15 JSTAlso reported by 1: Unite.AI
• 2026-10-02
  S2 Deal / PartnershipRakovina Therapeutics Partners with Boston-based Celvion Therapeutics to Leverage AI and Real-World Clinical Data for Precision Cancer Drug Development — biospace.com10/01 21:02 JST
• 2026-10-01
  S4 Amount disclosedOrtet launches with $500 million commitment for healthcare AI$500 million — The Pharma Letter10/01 01:19 JST
• 2026-10-01
  S1 DeploymentServier Adopts Veeva OpenData Globally to Scale AI — Morningstar09/30 20:03 JSTServierVeeva
• 2026-09-30
  S4 Amount disclosedRoche invests $2.4 billion to build an AI-driven autonomous lab; Phase 3 clinical trial success rate jumps to 80%$2.4 billion — BigGo ファイナンス09/30 14:25 JST
• 2026-09-23
  S4 Amount disclosedBoehringer Ingelheim bets up to $1B in AI-centered solid tumor collab with Envisagenicsup to $1B — biospace.com09/22 22:13 JSTBoehringer Ingelheim
• 2026-09-23
  S3 Capital moveTempus AI raises full-year outlook after 22% re... — Pluang09/22 20:28 JSTTempus AI
• 2026-09-22
  S4 Amount disclosedAnthropic's $400M Buy Gives New York's Life Sciences' AI Sector a Boost$400M — Globest09/21 21:10 JSTAnthropic
• 2026-09-22
  S2 Deal / PartnershipAbbVie partners with Iambic to apply AI platform across immunology, neuroscience, and oncology — AllSci09/22 00:01 JSTAbbVie
• 2026-09-22
  S2 Deal / PartnershipInsilico Medicine Cayman Topco Enters AI Co-Development Collaboration — TradingView09/21 19:19 JSTInsilico MedicineAlso reported by 1: marketscreener.com
• 2026-09-21
  S4 Amount disclosedByteDance spin-off Anew Labs raises US$290m as AI drug developers enjoy fundraising boomUS$290m — The Star09/20 20:00 JST
• 2026-09-21
  S4 Amount disclosedWhat Is Tempus AI (TEM)? The $98.5M Mark Behind Q2$98.5M — Phemex09/20 13:49 JSTTempus AI
• 2026-09-21
  S4 Amount disclosedMithrl Raises $20M to Scale Its Biopharma AI Infrastructure$20M — Wowtale09/20 08:03 JST
• 2026-09-20
  S4 Amount disclosedTempus AI(TEM.US) 10% Shareholder Sells US$16.11 Million in Common StockUS$16.11 Million — Moomoo09/19 10:35 JSTTempus AI
• 2026-09-20
  S2 Deal / PartnershipNovo Nordisk Bags Two EU Panel Wins, Unveils AI Alliance and Novo Rebrand Before London Strategy Day — ad-hoc-news.de09/19 22:31 JSTNovo Nordisk
• 2026-09-20
  S2 Deal / PartnershipNovo Nordisk stock gains as FREHEMGO and AI partnership sharpen growth story — ad-hoc-news.de09/19 19:20 JSTNovo Nordisk
• 2026-09-19
  S4 Amount disclosedByteDance spin-off Anew Labs raises US$290m amid AI drug design fundraising boomUS$290m — South China Morning Post09/18 12:00 JST
• 2026-09-19
  S3 Capital moveNAVER D2SF Invests in AI-Driven Precision Medicine Company ImpriMed — TradingView09/19 00:00 JST
• 2026-09-19
  S2 Deal / Partnership【AI healthcare stocks surge】Anthropic partners with Novo — will AI actually speed up new drug development? — Moomoo09/18 20:38 JSTAnthropic
• 2026-09-19
  S1 DeploymentAnthropic expands use of artificial intelligence in life sciences — Balkanweb.com09/19 01:08 JSTAnthropic
• 2026-09-18
  S4 Amount disclosedTempus AI (TEM) Extends Rally After Earnings Beat And $1.5B Deal$1.5B — StocksToTrade09/18 01:33 JSTTempus AI
• 2026-09-18
  S4 Amount disclosedCognita Imaging Receives $1.29 Million FDA Contract to Test New Approach to Evaluating Generative AI in Radiology$1.29 Million — BioSpace09/17 12:37 JST
• 2026-09-18
  S2 Deal / PartnershipNovo Nordisk deepens its AI push with Anthropic partnership — Baton Rouge Business Report09/17 23:33 JSTNovo NordiskAnthropic
• 2026-09-17
  S4 Amount disclosedByteDance completes $290 million fundraising for AI drug unit after its spin-off, sources say$290 million — whbl.com09/17 00:17 JST
• 2026-09-17
  S4 Amount disclosedTempus AI’s 10.7% Rally Centers on $200 Million of Data-License Bookings$200 Million — TechStock²09/16 20:51 JSTTempus AI
• 2026-09-17
  S3 Capital moveTikTok parent ByteDance raises cash for drug AI spinout Anew — pharmaphorum09/16 21:20 JST
• 2026-09-17
  S2 Deal / PartnershipCan Novo Nordisk’s Anthropic Partnership Drive an AI-Powered Turnaround? — NAI50009/16 22:11 JSTNovo NordiskAnthropic
• 2026-09-17
  S2 Deal / PartnershipNovo partners with Anthropic to speed up drug development with Claude — Yahoo Finance09/16 22:21 JSTAnthropic
• 2026-09-16
  S4 Amount disclosedOpenAI Foundation Gives $125M to Public Data for AI-Driven Health Program$125M — Inside Precision Medicine09/15 22:32 JSTOpenAI
• 2026-09-16
  S3 Capital moveTempus AI (TEM) Jumps As Upgrade, Acquisition Fuel Bullish Momentum — StocksToTrade09/16 01:33 JSTTempus AI
• 2026-09-16
  S1 DeploymentEisai introduces AI conversational role-playing service "Exabase Role-Playing" — PR TIMES09/15 08:30 JST
• 2026-09-16
  S1 DeploymentSTAT+: New documents reveal problems with Medicare’s prior-authorization pilot — STAT News09/15 22:06 JST
• 2026-09-15
  S4 Amount disclosedGraph AI Secures $13.3 Mn Series A To Scale AI Drug Safety Platform$13.3 Mn — BW Disrupt09/14 11:51 JST
• 2026-09-15
  S3 Capital moveSpotlight On: AI drug R&D is pulling venture dollars upstream - and why pharma should care — FirstWord Pharma09/15 00:32 JST
• 2026-09-15
  S1 DeploymentMedical AI company Aillis adopts Sakana AI's Japanese-specialized LLM in its generative AI tool for physicians, "Evidence Finder" — PR TIMES09/14 11:00 JST
• 2026-09-13
  S4 Amount disclosedFundly.ai Raises $4.9 Million to Expand B2B Pharma Platform$4.9 Million — Whalesbook09/12 22:14 JSTAlso reported by 1: Indian Startup News
• 2026-09-12
  S1 DeploymentOutSee secures £50,000 Innovate UK grant for agentic AI drug target validation pilot — Manufacturing Chemist09/11 20:53 JST
• 2026-09-12
  S1 DeploymentWhy Pharma's Next AI Challenge Is Supervision, Not Adoption — Pharmaceutical Commerce09/11 23:09 JST
• 2026-09-11
  S4 Amount disclosedFundly.ai raises $4 million in pharma distribution funding$4 million — Voice of Healthcare09/10 16:30 JST
• 2026-09-11
  S3 Capital moveDr. Thomas Clozel, Co-founder and CEO of Owkin – Interview Series — Unite.AI09/11 01:13 JSTOwkin
• 2026-09-10
  S4 Amount disclosedMajor Pharma News July–August 2026 | $400B Merger, AI, GLP-1s & India Pharma Updates Ben Stiller (oudY4ulATf)$400B — mshale.com09/09 05:54 JST
• 2026-09-10
  S4 Amount disclosedSTAT+: ARPA-H to invest $62 million to develop FDA-authorized AI to help treat heart failure$62.7 million — STAT News09/10 01:01 JST
• 2026-09-10
  S2 Deal / PartnershipPharma executives sentenced in $92M black-market HIV drug scheme; Trump reveals Rep. Neal Dunn’s serious heart diagnosis; AI model improves accuracy of cardiac ultrasound diagnoses – Morning Medical Update — Medical Economics09/09 18:14 JST
• 2026-09-10
  S1 DeploymentMandi Rollerson Takes on New AI Change and Adoption Leadership Role at Pfizer — hrtoday.in09/09 14:24 JSTPfizer
• 2026-09-10
  S1 DeploymentCiti Survey: Pharma AI Adoption High but Success Rate Expectations Low - News and Statistics — IndexBox09/09 21:53 JST
• 2026-09-10
  S1 DeploymentAI adoption hits 72 percent in pharmaceutical R&D: Citi Research — The Standard (HK)09/09 18:22 JST
• 2026-09-10
  S1 DeploymentVEEV: AI-driven innovation and strong CRM adoption are fueling growth and new opportunities in life sciences — tradingview.com09/10 01:19 JST
• 2026-09-08
  S2 Deal / Partnership2MM: AI Roundup: FDA clears autonomous blood draw robot, UHS acquires Talkspace, Databricks reaches $190 billion valuation, and AI-designed glioblastoma vaccine advances — 2 Minute Medicine09/08 23:04 JST
• 2026-09-08
  S2 Deal / PartnershipSanofi signs three-year partnership with Tricog to scale AI-powered cardiac diagnostics — Indian Pharma Post09/08 01:29 JSTSanofi
• 2026-09-08
  S1 DeploymentOutSee awarded Innovate UK grant for agentic AI pilot study to enhance drug target validation — Cambridge Network09/08 19:05 JST
• 2026-09-07
  S2 Deal / PartnershipOxyContin maker Purdue Pharma set to dissolve after $5B sentence; Mayo Clinic AI detects pancreatic cancer years before diagnosis; results of FDA’s largest-ever infant formula test – Morning Medical Update — Medical Economics09/07 18:37 JST
• 2026-09-07
  S2 Deal / PartnershipYap signs formal contract with Italy's Icarus, to rebuild its AI for handling initial medical facility phone calls for the Japanese market — PR TIMES09/07 10:00 JST
• 2026-09-05
  S1 DeploymentDoes Tempus AI’s (TEM) New ECG-PH Clearance Reveal Its Real Edge In Clinical AI Adoption? — simplywall.st09/05 05:20 JSTTempus AI
• 2026-09-04
  S2 Deal / PartnershipBoehringer Ingelheim signs AI agreement with Owkin — medwatch.com09/04 17:02 JSTBoehringer IngelheimOwkin
• 2026-09-03
  S4 Amount disclosedPharosyn Raises €2.5M for Pharma AI Intelligence Platform.€2.5M — konsulteer.com09/03 15:33 JST
• 2026-09-02
  S4 Amount disclosedSmart toilet, AI platform among tech in use at drugmaker Eli Lilly’s new S$42 million hub in Singapore$42 million — Singapore Economic Development Board (EDB)09/02 16:00 JSTEli Lilly
• 2026-09-02
  S4 Amount disclosedTempus AI Director Nadja West Sells 3,000 Shares for $207,000$207,000 — The Motley Fool09/02 22:35 JSTTempus AI
• 2026-09-02
  S2 Deal / PartnershipBoehringer Signs Deal for Owkin AI, Joining Astra and Sanofi — Bloomberg.com09/02 21:48 JSTSanofiOwkin
• 2026-09-02
  S2 Deal / PartnershipOno Pharmaceutical partners with Aitia to hunt new brain-disease drug targets using causal AI — Dealroom09/02 16:12 JSTOno PharmaceuticalAitia
• 2026-09-02
  S2 Deal / PartnershipCurveJen and Azabu University School of Veterinary Medicine take on AMR with One Health — jointly developing an AI system that identifies bovine mastitis-causing bacteria without relying on experience — 日経バイオテクONLINE09/02 21:29 JST
• 2026-09-01
  S4 Amount disclosedDassault Systèmes to Acquire ArisGlobal for Up to $2 Billion, Integrating Life Sciences AI$2 Billion — finance.biggo.com09/01 12:26 JST
• 2026-09-01
  S3 Capital moveTempus AI pulling, refiling US antitrust paperwork for Personalis buyout — MLex09/01 06:36 JSTTempus AI
• 2026-09-01
  S2 Deal / PartnershipWeave Bio Announces Collaboration with Takeda to Deploy AI-Native Regulatory Automation Across Key Drug Development Activities — Business Wire09/01 22:00 JSTTakedaAlso reported by 1: marketscreener.com
• 2026-09-01
  S1 DeploymentSaishunkan Pharmaceutical fully adopts AI voice operator — 週刊粧業オンライン09/01 11:30 JST
• 2026-08-31
  S2 Deal / PartnershipMegazone and Hanmi Science partner to jointly develop pharmaceutical AI - CHOSUNBIZ — Chosunbiz08/31 16:00 JST
• 2026-08-30
  S2 Deal / PartnershipWhat Chugai Pharmaceutical (TSE:4519)'s Agentic AI Partnership With Phylo Means For Shareholders — webull.com08/30 12:19 JSTChugai